Boston, MA — May 20, 2015 — Media Alert

Boston Biotech CEO Conference

In “Buy or Build? Discovery, Development and Commercial Perspectives,” L.E.K. Managing Director and Head of the Life Sciences and MedTech practice for the Americas, David Barrow, will moderate a panel of distinguished executives who will discuss the trade-offs and nuanced implications of different approaches to both R&D and commercialization. The theme is especially relevant today, as the increased availability of capital for emerging biopharma companies has heightened smaller players’ ability to consider going-it-alone rather than partnering or licensing.                    

Wednesday, May 27, 2015
Four Seasons Hotel
200 Boylston Street, Boston, MA

9:00 – 9:30 AM

About David Barrow:
David Barrow is the Head of the Biopharma, Life Sciences and MedTech practice for the Americas and has more than 17 years of experience in consulting at L.E.K., including corporate strategy development, mergers and acquisitions support, and global commercial planning. As a managing director and partner in our Biopharmaceuticals & Life Sciences and Healthcare Services practices, he has worked on more than 300 assignments with over 100 clients in a variety of sectors, including pharmaceuticals, biotechnology, medical devices, and diagnostics. Barrow has experience across a range of therapeutic areas, including CNS, infectious disease, oncology, and cardiovascular. Before joining L.E.K., he served as a paratrooper and military intelligence officer in the 82nd Airborne Division in the U.S. Army. He received his MBA in Finance from The Wharton School of Business, his Master of Arts in International Studies from The University of Pennsylvania, and his Bachelor of Arts in German from Dartmouth College.

About L.E.K. Consulting:
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and analytical rigor to help clients solve their most critical business problems. Founded more than 30 years ago, L.E.K. employs more than 1,000 professionals in 21 offices across Europe, the Americas and Asia-Pacific. L.E.K. advises and supports global companies that are leaders in their industries – including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. L.E.K. helps business leaders consistently make better decisions, deliver improved business performance and create greater shareholder returns.  

About The Boston Biotech CEO Conference:
The Boston Biotech CEO Conference is a networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world’s leading biopharmaceutical companies. Industry leaders in venture capital and private equity also participate.